Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-04-17 @ 2:06 PM
Study NCT ID:
NCT01747057
Status:
UNKNOWN
Last Update Posted:
2014-02-13
First Post:
2012-11-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Monitoring Resuscitation in Severe Sepsis and Septic Shock
Sponsor:
Corporacion Parc Tauli
Organization:
Study Overview
Official Title:
Monitoring Resuscitation in Severe Sepsis and Septic Shock
Status:
UNKNOWN
Status Verified Date:
2014-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our hypothesis is that hemodynamic fluid resuscitation guided by dynamic parameters will improve outcome in patients with severe sepsis and septic shock, by limiting the deleterious effects of fluid overload.
Detailed Description:
To evaluate the efficacy of dynamic parameters versus static measures to guide fluid resuscitation we pretend to detect a 10% relative reduction in mortality. In addition, we pretend to observe an improvement on the length of resuscitation time, mechanical ventilation and vasopressor support-free days, ICU and hospital length of stay, organ failure and renal function.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: